Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | What to expect in prostate cancer therapy in the future

Mark Fleming • 2 Jun 2019
ASCO 2019
Genitourinary Cancer Prostate Cancer Apalutamide

Here, Mark Fleming, MD, of Virginia Oncology, Norfolk, VA, discusses the next steps in treatment of prostate cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

More from Mark Fleming

0:53
PET/CT imaging scans for prostate cancers
Mark Fleming • 3 Jun 2019
3:12
Multiple treatment options for prostate cancer
Mark Fleming • 2 Jun 2019

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
0:45
SYNC-T combination immunotherapy in mCRPC
George Prendergast • 8 Apr 2024
0:40
PSMA PET findings in 225AC-J591-treated patients with mCRPC
Andres Ricaurte-Fajardo • 9 Apr 2024
0:45
Should radioligand therapies be used in earlier settings in prostate cancer?
Andres Ricaurte-Fajardo • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals